These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
186 related items for PubMed ID: 37541098
1. Assessment of synaptic loss in mouse models of β-amyloid and tau pathology using [18F]UCB-H PET imaging. Vogler L, Ballweg A, Bohr B, Briel N, Wind K, Antons M, Kunze LH, Gnörich J, Lindner S, Gildehaus FJ, Baumann K, Bartenstein P, Boening G, Ziegler SI, Levin J, Zwergal A, Höglinger GU, Herms J, Brendel M. Neuroimage Clin; 2023; 39():103484. PubMed ID: 37541098 [Abstract] [Full Text] [Related]
6. Tracing synaptic loss in Alzheimer's brain with SV2A PET-tracer UCB-J. Kumar A, Scarpa M, Nordberg A. Alzheimers Dement; 2024 Apr; 20(4):2589-2605. PubMed ID: 38363009 [Abstract] [Full Text] [Related]
9. Healthy brain aging assessed with [18F]FDG and [11C]UCB-J PET. Andersen KB, Hansen AK, Knudsen K, Schacht AC, Damholdt MF, Brooks DJ, Borghammer P. Nucl Med Biol; 2022 Apr; 112-113():52-58. PubMed ID: 35820300 [Abstract] [Full Text] [Related]
10. Reduced synaptic vesicle protein 2A binding in temporal lobe epilepsy: A [11 C]UCB-J positron emission tomography study. Finnema SJ, Toyonaga T, Detyniecki K, Chen MK, Dias M, Wang Q, Lin SF, Naganawa M, Gallezot JD, Lu Y, Nabulsi NB, Huang Y, Spencer DD, Carson RE. Epilepsia; 2020 Oct; 61(10):2183-2193. PubMed ID: 32944949 [Abstract] [Full Text] [Related]
11. A metabolically stable PET tracer for imaging synaptic vesicle protein 2A: synthesis and preclinical characterization of [18F]SDM-16. Zheng C, Holden D, Zheng MQ, Pracitto R, Wilcox KC, Lindemann M, Felchner Z, Zhang L, Tong J, Fowles K, Finnema SJ, Nabulsi N, Carson RE, Huang Y, Cai Z. Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1482-1496. PubMed ID: 34761284 [Abstract] [Full Text] [Related]
13. Evaluation of 18F-UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain. Warnock GI, Aerts J, Bahri MA, Bretin F, Lemaire C, Giacomelli F, Mievis F, Mestdagh N, Buchanan T, Valade A, Mercier J, Wood M, Gillard M, Seret A, Luxen A, Salmon E, Plenevaux A. J Nucl Med; 2014 Aug; 55(8):1336-41. PubMed ID: 24935992 [Abstract] [Full Text] [Related]
15. Synaptic Damage and Its Clinical Correlates in People With Early Huntington Disease: A PET Study. Delva A, Michiels L, Koole M, Van Laere K, Vandenberghe W. Neurology; 2022 Jan 04; 98(1):e83-e94. PubMed ID: 34663644 [Abstract] [Full Text] [Related]
17. Small-Animal PET Imaging of Tau Pathology with 18F-THK5117 in 2 Transgenic Mouse Models. Brendel M, Jaworska A, Probst F, Overhoff F, Korzhova V, Lindner S, Carlsen J, Bartenstein P, Harada R, Kudo Y, Haass C, Van Leuven F, Okamura N, Herms J, Rominger A. J Nucl Med; 2016 May 04; 57(5):792-8. PubMed ID: 26912432 [Abstract] [Full Text] [Related]
18. Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of Alzheimer's Disease. Kong Y, Maschio CA, Shi X, Xie F, Zuo C, Konietzko U, Shi K, Rominger A, Xiao J, Huang Q, Nitsch RM, Guan Y, Ni R. Mol Neurobiol; 2024 Oct 04; 61(10):8387-8401. PubMed ID: 38502413 [Abstract] [Full Text] [Related]